Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Earnings Release 2014

Jun 23, 2014

29755_rns_2014-06-23_d42e8086-322d-4171-9d38-adc256403da2.zip

Earnings Release

Open in viewer

Opens in your device viewer

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D. C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 or 15(d) of the*

*Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): June 23, 2014

*ABBVIE INC.*

(Exact name of registrant as specified in its charter)

Delaware 001-35565 32-0375147
(State or other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)

*1 North Waukegan Road*

*North Chicago, Illinois 60064-6400*

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (847) 932-7900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\105933\14-15821-1\task6839892\15821-1-ba.htm',USER='105933',CD='Jun 23 17:11 2014'

*Item 7.01. Regulation FD Disclosure.*

On June 23, 2014, AbbVie Inc. issued a press release announcing that it has raised the midpoint of its full-year 2014 earnings-per-share guidance. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

*Item 8.01. Other Events.*

As described in Item 7.01 above, on June 23, 2014, AbbVie Inc. announced that it has raised the midpoint of its full-year 2014 earnings-per-share guidance .

*Item 9.01. Financial Statements and Exhibits.*

Exhibit No. Exhibit
99.1 Press Release, dated June 23, 2014.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\105933\14-15821-1\task6839892\15821-1-ba.htm',USER='105933',CD='Jun 23 17:11 2014'

*SIGNATURE*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ WILLIAM J. CHASE
William J. Chase Executive Vice President, Chief Financial Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\105933\14-15821-1\task6839892\15821-1-ba.htm',USER='105933',CD='Jun 23 17:11 2014'

*EXHIBIT INDEX*

Exhibit No. Exhibit
99.1 Press Release, dated June 23, 2014.

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\105933\14-15821-1\task6839892\15821-1-ba.htm',USER='105933',CD='Jun 23 17:11 2014'